Skip to main content

Table 2 Prevalence of comorbidities in South Australian population and association with 1-year all-cause mortality

From: Developing a comorbidity index for comparing cancer outcomes in Aboriginal and non-Aboriginal Australians

Comorbidity n (%) Aboriginal aHR (95% CI)a weight n (%) non-Aboriginal aHR (95% CI) a weight
Alcohol abuse 77 (9.9) 1.73 (1.25–2.39) 2 13 (1.7) 1.07 (0.44–2.64) 1
AMI 32 (4.1) 1.24 (0.75–2.04) 1 8 (1.0) 0.68 (0.21–2.18) 0
Angina 38 (4.9) 1.21 (0.78–1.89) 1 13 (1.7) 2.48 (1.06–5.82) 2
Anxiety and behavioural disorders 14 (1.8) 1.08 (0.44–2.66) 1 8 (1.0) 1.46 (0.35–6.01) 1
Blood loss anaemia 11 (1.4) 1.42 (0.52–3.88) 1 ** ** **
Bowel disease 18 (2.3) 1.10 (0.54–2.25) 1 5 (0.6) 11.17 (3.73–33.5) 11
Cardiac arrhythmias 30 (3.9) 0.80 (0.46–1.41) 0 22 (2.8) 0.99 (0.46–2.14) 0
CHF 36 (4.6) 1.48 (0.96–2.28) 1 14 (1.8) 2.09 (1.00–4.37) 2
Chronic viral hepatitis 18 (2.3) 0.97 (0.45–2.10) 0 ** ** **
Coagulopathy 18 (2.3) 1.06 (0.46–2.41) 1 9 (1.2) 1.36 (0.42–4.49) 1
COPD 83 (10.7) 1.13 (0.81–1.59) 1 34 (4.4) 1.64 (0.92–2.90) 2
CVD 26 (3.4) 1.33 (0.74–2.40) 1 15 (1.9) 2.12 (1.07–4.13) 2
Deficiency anaemia 22 (2.8) 1.07 (0.56–2.01) 1 14 (1.8) 0.81 (0.29–2.27) 0
Dementia 6 (0.8) 0.67 (0.16–2.72) 0 ** ** **
Depression 20 (2.6) 1.00 (0.49–2.04) 1 9 (1.2) 1.14 (0.28–4.64) 1
Diabetes complicated 58 (7.5) 1.13 (0.76–1.68) 1 6 (0.8) 1.27 (0.17–9.31) 1
Diabetes without complications 84 (10.8) 1.01 (0.72–1.42) 1 21 (2.7) 2.67 (1.39–5.13) 3
Drug abuse 29 (3.7) 0.97 (0.54–1.75) 0 6 (0.8) 2.34 (0.73–7.52) 2
Epilepsy 13 (1.7) 1.26 (0.55–2.88) 1 6 (0.8) 4.11 (1.27–13.3) 4
Eye problems 16 (2.1) 1.50 (0.83–2.70) 1 ** ** **
Fluid and electrolyte disorders 18 (2.3) 1.43 (0.75–2.71) 1 9 (1.2) 3.22 (1.40–7.38) 3
Hypertension uncomplicated 105 (13.5) 1.01 (0.74–1.38) 1 55 (7.1) 1.07 (0.63–1.80) 1
Hypothyroidism 12 (1.5) 1.77 (0.78–4.04) 2 ** ** **
Intestinal disorders 14 (1.8) 0.86 (0.35–2.12) 0 15 (1.9) 0.58 (0.18–1.85) 0
Joint and spinal disorders 5 (0.6) 2.62 (0.64–10.8) 3 ** ** **
Metabolic disorders 48 (6.2) 1.31 (0.88–1.95) 1 13 (1.7) 0.87 (0.32–2.36) 0
Mild liver disease 24 (3.1) 2.00 (1.17–3.40) 2 ** ** **
Moderate/Severe liver disease ** ** ** 6 (0.8) 3.23 (1.29–8.05) 3
Obesity 17 (2.2) 0.61 (0.22–1.64) 0 ** ** **
Osteoporosis 6 (0.8) 0.82 (0.26–2.59) 0 ** ** **
Other cardiac conditions 58 (7.5) 1.34 (0.92–1.95) 1 14 (1.8) 2.97 (1.35–6.56) 3
Other neurological disorders 11 (1.4) 0.90 (0.28–2.85) 0 ** ** **
Pancreatitis 6 (0.8) 0.80 (0.20–3.23) 0 ** ** **
Paralysis 13 (1.7) 1.89 (0.83–4.30) 2 9 (1.2) 2.31 (1.06–5.02) 2
Peptic ulcer 18 (2.3) 0.95 (0.46–1.94) 0 15 (1.9) 1.25 (0.51–3.09) 1
Psychoses 23 (3) 1.43 (0.75–2.72) 1 8 (1.0) 1.10 (0.27–4.46) 1
Pulmonary circulation disorders 7 (0.9) 0.79 (0.29–2.20) 0 ** ** **
PVD 6 (0.8) 0.23 (0.03–1.67) 0 6 (0.8) 1.23 (0.30–5.02) 1
Renal disease 34 (4.4) 2.37 (1.55–3.62) 2 5 (0.6) 8.56 (2.53–28.9) 9
Rheumatoid disease 7 (0.9) 1.77 (0.65–4.84) 2 6 (0.8) 1.77 (0.65–4.84) 2
Sleep disorders 5 (0.6) 1.91 (0.60–6.08) 2 ** ** **
Urinary tract disorders 7 (0.9) 2.19 (0.87–5.52) 2 ** ** **
Valvular diseases 13 (1.7) 1.48 (0.65–3.39) 1 6 (0.8) 1.46 (0.20–10.7) 1
Weight loss 17 (2.2) 2.97 (1.71–5.16) 3 7 (0.9) 1.21 (0.30–4.94) 1
  1. Abbreviations: AMI acute myocardial infarction, COPD chronic obstructive pulmonary diseases, CVD cerebrovascular disease, CHF congestive heart failure
  2. aadjusted for age, sex, stage, primary site
  3. **excluded from the model, prevalence = < 0.5%